☰
✕

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Premium

Hedge Funds-News

Billionaire Druckenmiller’s 5 Stocks Picks with Huge Upside Potential

Published on December 8, 2023 at 8:55 am by Ruchi Gupta in Hedge Funds, News

In this piece, we will take a look at billionaire Druckenmiller’s 5 stocks picks with huge upside potential. If you want to read our introduction to Mr. Druckenmiller in general, then head over to Billionaire Druckenmiller’s 10 Stocks Picks with Huge Upside Potential.

5. Transocean Ltd (NYSE:RIG)

Duquesne Capital’s Equity Stake: $15.14 Million
Share Price Upside Potential: 53.06%
Number of Hedge Fund Holders: 47

Transocean Ltd (NYSE:RIG) is a company that offers offshore contract drilling services for oil and gas wells. It is an energy investment play in the portfolio of Duquesne Capital. Transocean Ltd (NYSE:RIG) contracts its mobile offshore drilling rig-related equipment and world crew for drilling oil and gas wells.

In addition to being a billionaire Druckenmiller stock pick with tremendous upside potential, Transocean Ltd (NYSE:RIG) has outperformed the overall market as it is up by about 47% for the year. Analysts have an average $9.75 price target on the stock, implying a 53.06% upside potential from current levels. Druckenmiller acquired 1.8 million shares in Transocean Ltd (NYSE:RIG) in Q3 2023, valued at about $15.14 million and accounting for 0.54% of the portfolio.

As of Q3 2023, 47 of the 910 hedge funds tracked by Insider Monkey held Transocean Ltd (NYSE:RIG) shares, up from 38 in the previous quarter. D. E. Shaw’s D E Shaw was its largest hedge fund shareholder with ownership of about 22 million shares valued at $183.05 million.

Follow Transocean Ltd. (NYSE:RIG)
[/company-follow-email]

4. Alibaba Group Holding Limited (NYSE:BABA)

Duquesne Capital’s Equity Stake: $26.67 Million
Share Price Upside Potential: 70.81%
Number of Hedge Fund Holders: 110

Alibaba Group Holding Limited (NYSE:BABA) is one billionaire Druckenmiller stock pick with tremendous upside potential that offers exposure to the Chinese internet landscape. The company is one of the largest e-commerce players, offering platforms that connect merchants with sellers. Alibaba Group Holding Limited (NYSE:BABA) also provides a cloud computing unit with storage, analytics, and cybersecurity solutions.

Alibaba Group Holding Limited (NYSE:BABA) has underperformed the overall market, down by about 17% for the year. Nevertheless, analysts rate it as a Buy with an average price target of $124.74, implying 70.81% upside potential. Alibaba Group Holding Limited (NYSE:BABA) is one of the new additions to Druckenmiller’s portfolio, with the acquisition of stakes worth $26.67 million in Q3 2023 accounting for 0.95% of the portfolio.

During Q3 2023, 110 out of the 910 hedge funds part of Insider Monkey’s database were Alibaba Group Holding Limited (NYSE:BABA)’s shareholders. Alibaba Group Holding Limited (NYSE:BABA)’s most significant investor during Q3 was Ken Fisher’s Fisher Asset Management as it owned $334 million worth of shares.

Follow Alibaba Group Holding Ltd (NYSE:BABA)
[/company-follow-email]

3. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Duquesne Capital’s Equity Stake: $6.94 Million
Share Price Upside Potential: 124.02%
Number of Hedge Fund Holders: 19

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a healthcare investment in Duquesne Capital’s portfolio that operates as a clinical-stage biotechnology company. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) leverages technological innovations, data science, and engineering to enhance drug discovery. It is currently working on REC 994 to treat cerebral cavernous malformation.

While Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is down by about 4% for the year, it is one of the billionaire Druckenmiller stock picks with tremendous upside potential. Analysts on Wall Street rate it as a Buy with an average price target of $16.60, implying 124.02% upside potential from current levels. Druckenmiller reduced his stock exposure in Q3 2023 by 35% to $6.9 million, accounting for 0.24% of the portfolio.

As per Insider Monkey’s database, 19 hedge funds held stakes in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) in Q3 2023, compared to 15 funds in the prior quarter. Mubadala Investment’s 

MIC Capital Partners is the leading shareholder of the company, with stakes worth $64.66 million.

Follow Recursion Pharmaceuticals Inc. (NASDAQ:RXRX)
[/company-follow-email]

2. IHS Holding Limited (NYSE:IHS) 

Duquesne Capital’s Equity Stake: $3.42 Million
Share Price Upside Potential: 144.68%
Number of Hedge Fund Holders: 14

London-based IHS Holding Limited (NYSE:IHS) is a communication services company that owns, operates, and develops shared communications infrastructure. IHS Holding Limited (NYSE:IHS) primarily works in Latin America, Sub-Saharan Africa, and the Middle East. 

IHS Holding Limited (NYSE:IHS) has underperformed the overall market, going down 24% year to date. Nevertheless, IHS Holding Limited (NYSE:IHS) remains one billionaire Druckenmiller’s stock picks with huge upside potential going by the $11.50 price target, which implies 144.68% upside potential.

Out of the 910 hedge funds tracked by Insider Monkey, 14 funds had investments in IHS Holding Limited (NYSE:IHS)’s stock in the third quarter, down from 15 in the previous quarter.

Follow Ihs Inc. (NYSE:IHS)
[/company-follow-email]

1. AbCellera Biologics Inc. (NASDAQ:ABCL)

Duquesne Capital’s Equity Stake: $3.04 Million
Share Price Upside Potential: 417.24%
Number of Hedge Fund Holders: 17

AbCellera Biologics Inc. (NASDAQ:ABCL) is billionaire Druckenmiller’s top stock pick with tremendous upside potential with operations in the healthcare sector. AbCellera Biologics Inc. (NASDAQ: ABCL) values its research collaboration and license agreement with Eli Lilly.

Druckenmiller has held stakes in AbCellera Biologics Inc. (NASDAQ:ABCL) since the fourth quarter of last year at the height of the bear run. Duquesne Capital held stakes worth $3 million in the company in Q3 2023, accounting for 0.1% of the portfolio. While AbCellera Biologics Inc. (NASDAQ:ABCL) is down by about 52%, analysts on Wall Street are bullish about its prospects, with a $24 price target implying a 417.24% upside potential.

In the third quarter of 2023, 17 hedge funds had stakes in AbCellera Biologics Inc. (NASDAQ:ABCL), according to Insider Monkey’s database. Baker Bros. Advisors, led by Julian Baker and Felix Baker, was the leading stakeholder in the company.

Follow Abcellera Biologics Inc. (NASDAQ:ABCL)
[/company-follow-email]

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily newsletter to get  the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out our articles on 15 Stocks under $50 to Buy and Hold Forever and Billionaire Daniel Sundheim’s D1 Capital Portfolio: Top 12 Stock Picks.

Show more...

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on May 16, 2026 at by Inan Dogan, PhD
Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Insider Monkey Ads

Buy This $3 Stock Now Before the 400% Surge Begins

Published on May 15, 2026 at by Inan Dogan, PhD
Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returns! Sign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Here’s why this is a deal you can’t afford to pass up:

  • Access to our Detailed Report on this $3 stock with 400% upside potential.
  • BONUS REPORT on our #1 AI-Robotics Stock with 10000% upside potential: Our in-depth report dives deep into our #1 AI/robotics stock’s groundbreaking technology and massive growth potential.
  • One New Issue of Our Premium Readership Newsletter: You will also receive one new issue per month and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.
  • One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149
  • Bonus Content: Premium access to members-only fund manager video interviews
  • Ad-Free Browsing: Enjoy a month of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
  • Lifetime Price Guarantee: Your renewal rate will always remain the same as long as your subscription is active.
  • 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.

Related Insider Monkey Articles
11 Stocks Under $25 To Buy Now
Bill Gates' 10 Stock Picks with Huge Upside Potential
5 Stocks Dr Michael Burry Just Bought and Sold
11 Most Volatile Stocks Under $5 For Day Trading
5 Stocks Under $25 To Buy Now
Insider Monkey Quarterly Strategy
+599.2% Insider Monkey Quarterly Strategy
+227% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
500%
250%
0%

Returns since its inception in May 2014 (through June 2, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.

Past performance does not guarantee future returns. Click to see how the portfolio is constructed.

Home Hedge Funds Markets Blog Site Map
Authors About Us Contact Us Privacy Policy Terms of Use FAQ CCPA - Do Not Sell My Information
All text and design is copyright © 2026 InsiderMonkey.com. All rights reserved.